Skip to content
Storytelling Co – Lifestyle
Author:
Oryzon Genomics, S.A.
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
May 14, 2026
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
May 13, 2026
←
Previous Page
1
2